Diana Brixner is currently Professor and Chair of the Department of Pharmacotherapy at the University of Utah College of Pharmacy in Salt Lake City. She is also Executive Director of the Pharmacotherapy Outcomes Research Center, affiliated with the University of Utah Health Sciences Center, where she focuses on the design, conduct, training and communication of pharmacoeconomic and outcomes research studies to demonstrate the value of pharmaceutical therapy.

Prior to this appointment Dr. Brixner was the Vice President of Health Care Management for Novartis Pharmaceuticals, based in East Hanover, New Jersey, from 1994 to 1999. For the next three years she served as Regional Sales Director and then Executive Director of National Managed Care Accounts.

Previously Dr. Brixner held various positions at SmithKlineBeecham, both in the Northwest and at corporate headquarters in Philadelphia, conducting work in pharmacoeconomics, outcomes research, and disease management in collaboration with managed care organizations. Diana worked for three years at the biotechnology company NeoRx in Seattle, Washington conducting drug discovery research and development of a lecture series for pharmacists entitled “Biotechnology: Impact on Pharmacy”. She served a presidential term from 2006-2009 with ISPOR (International Society for Pharmacoeconomics and Outcomes Research).

Dr. Brixner received her undergraduate degree in pharmacy in 1982 from the University of Rhode Island and her doctorate in medicinal chemistry in 1987 from the University of Utah. Dr. Brixner previously held an adjunct faculty position at the College of Pharmacy at the University of the Sciences in Philadelphia, Pennsylvania.